Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 125 of the 126 references it cites were found in a registry or an index.

Prevention of malaria in pregnancy

Desai, Meghna, Hill, Jenny, Fernandes, Silke, Walker, Patrick, Pell, Christopher, Gutman, Julie, Kayentao, Kassoum, Gonzalez, Raquel, Webster, Jayne, Greenwood, Brian, Cot, Michel, ter Kuile, Feiko O · 2018 · The Lancet Infectious Diseases

Abstract

Malaria remains one of the most preventable causes of adverse birth outcomes. Intermittent preventive treatment in pregnancy (IPTp) with sulfadoxine-pyrimethamine is used to prevent malaria, but resistance to this drug combination has decreased its efficacy and new alternatives are needed. In Africa, a meta-analysis showed three-course or monthly IPTp with sulfadoxine-pyrimethamine to be safe and more effective than the original two-course sulfadoxine-pyrimethamine strategy, prompting WHO to update its policy in 2012. Although resistance to sulfadoxine-pyrimethamine reduces the parasitological efficacy of IPTp, this drug combination remains associated with reduced incidence of low birthweight in areas where prevalence of parasites with quintuple Plasmodium falciparum dihydrofolate reductase (Pfdhfr) and dihydropteroate synthetase (Pfdhps) mutations is greater than 90%. Nevertheless, its effectiveness is compromised in women infected with sextuple mutant parasites. Six trials of IPTp showed that neither amodiaquine, mefloquine, nor chloroquine-azithromycin are suitable replacements for sulfadoxine-pyrimethamine because of poor tolerability. Furthermore, four trials showed that intermittent screening and treatment with the current generation of malaria rapid diagnostic tests was not a suitable alternative strategy to IPTp with sulfadoxine-pyrimethamine, even in areas with high prevalence of quintuple mutations. Two trials showed that IPTp with dihydroartemisinin-piperaquine was well tolerated, effective, and acceptable for IPTp, with monthly regimens being the most effective. Coverage of IPTp and insecticide-treated nets continues to lag behind targets. The key barriers to uptake are well documented, and many are open to intervention. Outside of Africa, a single trial suggests a potential role for integrated approaches that combine sulfadoxine-pyrimethamine with azithromycin for IPTp in areas of Papua New Guinea where malaria transmission is high. Modelling analysis suggests the importance of the prevention of malaria early in pregnancy and the need to protect pregnant women declines more slowly than the rate at which transmission declines. Improved funding has led to an increase in the number of prevention trials in the past decade, showing the value of more sustained protection with monthly IPTp regimens. There is a need for confirmatory trials of the safety, efficacy, and feasibility of IPTp with dihydroartemisinin-piperaquine, for studies of intermittent screening and treatment with more sensitive rapid diagnostic tests, for studies of integrated strategies for malaria and other co-infections, and for studies of prevention strategies for malaria in pregnant women who are HIV-positive and living outside of Africa. Additional research is required on how to improve uptake of WHO's updated policy on IPTp with sulfadoxine-pyrimethamine and insecticide-treated nets.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1473-3099(18)30064-1

Cites

125 of 125 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 126 references

Research works printed but not linked: 1

  1. Tarning, 2016, Treatment of malaria in pregnancy, N Engl J Med, 374, 981, 10.1056/nejme1601193 · DOI

Cited by

See all 190

Metadata

Authors
Desai, M., Hill, J., Fernandes, S., Walker, P., Pell, C., Gutman, J., Kayentao, K., Gonzalez, R., Webster, J., Greenwood, B., Cot, M., & ter Kuile, F. O.
Affiliations
  • Centers for Disease Control and Prevention (US)
  • Liverpool School of Tropical Medicine (GB)
  • London School of Hygiene & Tropical Medicine (GB)
  • Imperial College London (GB)
  • University of Amsterdam (NL)
  • Université des Sciences, des Techniques et des Technologies de Bamako (ML)
  • Santé Internationale de la mère et de l'enfant (FR)
Corresponding author
Desai, Meghna
Venue
The Lancet Infectious Diseases
Publisher
Elsevier BV
Published
2018-04
Volume
18
Issue
4
Pages
e119-e132
ISSN
1473-3099 (ISSN-L)
OpenAlex
W2786033909
Cited by
153
References
126
Citations by year
2026: 6 · 2025: 16 · 2024: 18 · 2023: 18 · 2022: 24 · 2021: 18 · 2020: 21 · 2019: 20 · 2018: 12
FWCI
3.22
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • The Lancet Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
  • LSTM Online Archive (Liverpool School of Tropical Medicine) (acceptedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (submittedVersion)
Funders
Medical Research Council (MC_PC_MR/P006914/1, MR/R015600/1)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Global Maternal and Child Health
  • Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Keywords
malaria in pregnancy, intermittent preventive treatment in pregnancy, sulfadoxine-pyrimethamine, dihydroartemisinin-piperaquine, antimalarial drug resistance, Plasmodium falciparum, low birth weight, intermittent screening and treatment, rapid diagnostic tests, amodiaquine, mefloquine, insecticide-treated nets
MeSH terms
Africa, Antimalarials, Clinical Trials as Topic, Drug Resistance, Drug Therapy, Combination, Female, Humans, Papua New Guinea, Pregnancy, Pregnancy Complications, Infectious, Malaria, Falciparum, Disease Transmission, Infectious, Chemoprevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prevention of malaria in pregnancy. https://app.cochat.ai/papers/10.1016/s1473-3099(18)30064-1
The paper
Desai, M., Hill, J., Fernandes, S., Walker, P., Pell, C., Gutman, J., Kayentao, K., Gonzalez, R., Webster, J., Greenwood, B., Cot, M., & ter Kuile, F. O. (2018). Prevention of malaria in pregnancy. The Lancet Infectious Diseases. https://doi.org/10.1016/s1473-3099(18)30064-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.